Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MannKind: Approval For Afrezza Looking More And More Positive As Investors Await FDA Decision
MannKind: Approval For Afrezza Looking More And More Positive As Investors Await FDA Decision
MannKind: Approval For Afrezza Looking More And More Positive As Investors Await FDA Decision
Submitted by
admin
on May 19, 2014 - 10:45am
Source:
Seeking Alpha
News Tags:
MannKind
diabetes
inhaled insulin
Afrezza
Headline:
MannKind: Approval For Afrezza Looking More And More Positive As Investors Await FDA Decision
Do Not Allow Advertisers to Use My Personal information